• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

庆大霉素不同剂量和不同给药频率方案的前瞻性对比研究

Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin.

作者信息

Goodman E L, Van Gelder J, Holmes R, Hull A R, Sanford J P

出版信息

Antimicrob Agents Chemother. 1975 Oct;8(4):434-8. doi: 10.1128/AAC.8.4.434.

DOI:10.1128/AAC.8.4.434
PMID:1103724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC429365/
Abstract

In patients with impaired renal function, careful adjustment of gentamicin dosage is required to achieve therapeutic yet nontoxic concentrations. Two regimens that differ in pharmacodynamic characteristics have been recommended for this purpose: prolonging the intervals between administration of equal doses (variable frequency regimen [VFR]) or administering a loading dose followed at the usual intervals by reduced maintenance doses (variable dosage regimen [VDR]). These regimens were compared in a prospective, randomized study of 20 seriously ill hospitalized patients, 10 on VFR and 10 on VDR. Wide variability in peak serum levels of gentamicin was observed both between patients and in individual patients after separate injections of the same dosage. As predicted by the design of these regimens, the trough serum levels of gentamicin correlated significantly with the serum creatinine concentrations in patients on the VDR but not in patients on the VFR. A gentamicin trough level of >/=4 mug/ml was the only variable among those tested that correlated significantly with development or progression of renal insufficiency during treatment with gentamicin, but such trough levels were observed frequently on both regimens. Whereas this study does not permit a direct comparison of the therapeutic efficacy of VDR and VFR, no difference in the risk of nephrotoxicity with these regimens was observed.

摘要

对于肾功能受损的患者,需要仔细调整庆大霉素剂量,以达到治疗浓度且无毒副作用。为此推荐了两种药效学特征不同的给药方案:延长等剂量给药的间隔时间(可变频率方案[VFR])或先给予负荷剂量,随后按常规间隔给予减量维持剂量(可变剂量方案[VDR])。在一项针对20例重症住院患者的前瞻性随机研究中对这两种方案进行了比较,其中10例采用VFR,10例采用VDR。在患者之间以及同一患者单独注射相同剂量后,庆大霉素的血清峰值水平存在很大差异。正如这些方案的设计所预测的那样,VDR患者的庆大霉素谷值水平与血清肌酐浓度显著相关,而VFR患者则不然。庆大霉素谷值水平≥4μg/ml是所检测的变量中唯一与庆大霉素治疗期间肾功能不全的发生或进展显著相关的变量,但两种方案中均频繁观察到这样的谷值水平。虽然这项研究不允许直接比较VDR和VFR的治疗效果,但未观察到这两种方案在肾毒性风险方面存在差异。

相似文献

1
Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin.庆大霉素不同剂量和不同给药频率方案的前瞻性对比研究
Antimicrob Agents Chemother. 1975 Oct;8(4):434-8. doi: 10.1128/AAC.8.4.434.
2
Dosage schedule of gentamicin for chronic renal insufficiency in children.儿童慢性肾功能不全患者庆大霉素的给药方案
Arch Dis Child. 1978 Apr;53(4):334-7. doi: 10.1136/adc.53.4.334.
3
One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.与每日多次剂量的庆大霉素相比,每日一剂治疗新生儿疑似或确诊败血症。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD005091. doi: 10.1002/14651858.CD005091.pub2.
4
A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate.
Am J Med. 1998 Sep;105(3):182-91. doi: 10.1016/s0002-9343(98)00244-7.
5
Gentamicin dosing in neonatal patients.新生儿患者的庆大霉素给药剂量。
Pharm World Sci. 2001 Oct;23(5):179-80. doi: 10.1023/a:1012221801816.
6
Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age.孕周<32周且日龄>7天的早产新生儿庆大霉素延长给药间隔方案
Clin Ther. 2017 Jun;39(6):1233-1241. doi: 10.1016/j.clinthera.2017.05.343. Epub 2017 May 31.
7
The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure.给药方案对实验性庆大霉素肾毒性的影响:血清峰值水平与肾衰竭的分离
J Infect Dis. 1979 Oct;140(4):576-80. doi: 10.1093/infdis/140.4.576.
8
Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits.与家兔庆大霉素肾毒性相关的药理学因素。
J Infect Dis. 1977 Jun;135(6):952-6. doi: 10.1093/infdis/135.6.952.
9
Gentamicin in neonatal infection: once versus twice daily dosage.庆大霉素用于新生儿感染:每日一次与每日两次给药剂量对比
J Med Assoc Thai. 2001 Aug;84(8):1109-15.
10
Once-daily gentamicin dosing in newborn infants.新生儿每日一次庆大霉素给药。
Pediatrics. 1999 Jun;103(6 Pt 1):1228-34. doi: 10.1542/peds.103.6.1228.

引用本文的文献

1
Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).腹腔内注射庆大霉素在腹膜炎患者腹膜透析中的药代动力学(GIPD 研究)。
Clin J Am Soc Nephrol. 2012 Aug;7(8):1249-56. doi: 10.2215/CJN.12211211. Epub 2012 Jun 14.
2
Therapeutic drug monitoring of aminoglycosides in neonates.新生儿氨基糖苷类药物的治疗药物监测
Clin Pharmacokinet. 2009;48(2):71-88. doi: 10.2165/00003088-200948020-00001.
3
Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌感染患者中阿贝卡星的群体药代动力学。
Antimicrob Agents Chemother. 2006 Nov;50(11):3754-62. doi: 10.1128/AAC.00420-05.
4
Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?每日一次氨基糖苷类药物治疗。它的毒性是否低于每日多次给药,以及应如何进行监测?
Clin Pharmacokinet. 1999 Feb;36(2):89-98. doi: 10.2165/00003088-199936020-00001.
5
Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?
Clin Pharmacokinet. 1998 Apr;34(4):265-79. doi: 10.2165/00003088-199834040-00001.
6
Cost considerations in therapeutic drug monitoring of aminoglycosides.氨基糖苷类药物治疗药物监测中的成本考量
Clin Pharmacokinet. 1994 Jan;26(1):71-81. doi: 10.2165/00003088-199426010-00006.
7
What is the evidence for once-daily aminoglycoside therapy?每日一次氨基糖苷类药物治疗的证据是什么?
Clin Pharmacokinet. 1994 Jul;27(1):32-48. doi: 10.2165/00003088-199427010-00004.
8
Basis for an adequate dosage of aminoglycoside antibiotics.
Infection. 1980;Suppl 1:58-61. doi: 10.1007/BF01644937.
9
Antimicrobial chemotherapy - a clinician's viewpoint.
Experientia. 1980 Apr 15;36(4):476-9. doi: 10.1007/BF01975158.
10
Performance characteristics of bioassay, radioenzymatic assay, homogeneous enzyme immunoassay, and high-performance liquid chromatographic determination of serum gentamicin.生物测定、放射酶测定、均相酶免疫测定以及血清庆大霉素的高效液相色谱测定的性能特征
Antimicrob Agents Chemother. 1982 Jan;21(1):19-25. doi: 10.1128/AAC.21.1.19.

本文引用的文献

1
Dose of gentamicin in patients with normal renal function and renal impairment.正常肾功能和肾功能损害患者的庆大霉素剂量。
Br Med J. 1968 Apr 6;2(5596):19-22. doi: 10.1136/bmj.2.5596.19.
2
Clinical research experience with gentamicin. Incidence of adverse reactions.庆大霉素的临床研究经验。不良反应发生率。
Med J Aust. 1970 Jun 13;1:Suppl:30-4.
3
Pharmacology of gentamicin in man.庆大霉素在人体中的药理学。
J Infect Dis. 1971 Dec;124 Suppl:S98-105. doi: 10.1093/infdis/124.supplement_1.s98.
4
Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States.庆大霉素对人体的耳毒性:美国临床经验的调查与对照分析
J Infect Dis. 1971 Dec;124 Suppl:S130-7. doi: 10.1093/infdis/124.supplement_1.s130.
5
Correlation of serum creatinine concentration and gentamicin half-life.血清肌酐浓度与庆大霉素半衰期的相关性。
JAMA. 1972 Feb 21;219(8):1037-41.
6
Relation between dose and levels of gentamicin in blood.庆大霉素血药浓度与剂量的关系。
J Infect Dis. 1971 Dec;124 Suppl:S90-5. doi: 10.1093/infdis/124.supplement_1.s90.
7
Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration.肾功能不全患者的庆大霉素剂量。根据内生肌酐清除率和血清肌酐浓度进行调整。
Ann Intern Med. 1971 Feb;74(2):192-7. doi: 10.7326/0003-4819-74-2-192.
8
The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.庆大霉素血清浓度的不可预测性:肾功能正常和异常患者的庆大霉素药代动力学
J Infect Dis. 1974 Aug;130(2):150-4. doi: 10.1093/infdis/130.2.150.
9
Letter: Creatinine clearance: bedside estimate.
Ann Intern Med. 1973 Oct;79(4):604-5. doi: 10.7326/0003-4819-79-4-604.
10
Gentamicin therapy in renal failure: a nomogram for dosage.肾衰竭患者的庆大霉素治疗:剂量列线图
Ann Intern Med. 1972 May;76(5):773-8. doi: 10.7326/0003-4819-76-5-773.